These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia. de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348 [TBL] [Abstract][Full Text] [Related]
25. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase. Toll AD; Boman BM; Palazzo JP Hum Pathol; 2012 Feb; 43(2):238-42. PubMed ID: 21820149 [TBL] [Abstract][Full Text] [Related]
27. Systematic review with meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia. Wan J; Wang X; Zhang Y; Chen M; Wang M; Wu K; Liang J Aliment Pharmacol Ther; 2022 Mar; 55(6):632-644. PubMed ID: 35166389 [TBL] [Abstract][Full Text] [Related]
28. Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study. Harpaz N; Goldblum JR; Shepherd NA; Riddell RH; Rubio CA; Vieth M; Wang HH; Odze RD Hum Pathol; 2023 Aug; 138():49-61. PubMed ID: 37247824 [TBL] [Abstract][Full Text] [Related]
29. Non-conventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease-results of molecular and immunohistochemical single institutional study. Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J Virchows Arch; 2020 Feb; 476(2):231-241. PubMed ID: 31375911 [TBL] [Abstract][Full Text] [Related]
30. Non-conventional types of dysplastic changes in gastrointestinal tract mucosa - review of morphological features of individual subtypes. Kamaradová K Cesk Patol; 2022; 58(1):38-51. PubMed ID: 35387456 [TBL] [Abstract][Full Text] [Related]
31. Serrated colorectal polyps in inflammatory bowel disease. Ko HM; Harpaz N; McBride RB; Cui M; Ye F; Zhang D; Ullman TA; Polydorides AD Mod Pathol; 2015 Dec; 28(12):1584-93. PubMed ID: 26403785 [TBL] [Abstract][Full Text] [Related]
32. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance. Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183 [TBL] [Abstract][Full Text] [Related]
33. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching. Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR; Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507 [TBL] [Abstract][Full Text] [Related]
34. Importance of nonpolypoid (flat and depressed) colorectal neoplasms in screening for CRC in patients with IBD. Rutter MD Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):327-35. PubMed ID: 24975524 [TBL] [Abstract][Full Text] [Related]
35. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients. Gui X; Iacucci M; Ghosh S Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687 [TBL] [Abstract][Full Text] [Related]
36. Longitudinal outcomes of the endoscopic resection of nonpolypoid dysplastic lesions in patients with inflammatory bowel disease. Kaltenbach T; Holmes I; Nguyen-Vu T; Malvar C; Balitzer D; Fong D; Fu A; Shergill A; McQuaid K; Soetikno R Gastrointest Endosc; 2023 May; 97(5):934-940. PubMed ID: 36649745 [TBL] [Abstract][Full Text] [Related]
37. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Pascal RR Hum Pathol; 1994 Nov; 25(11):1160-71. PubMed ID: 7959660 [TBL] [Abstract][Full Text] [Related]
38. Non-conventional dysplasia is frequently associated with low-grade tubuloglandular and mucinous adenocarcinomas in inflammatory bowel disease. Akarca FG; Yozu M; Alpert L; Kővári BP; Zhao L; Salomao M; Liao X; Westerhoff M; Lauwers GY; Choi WT Histopathology; 2023 Aug; 83(2):276-285. PubMed ID: 37055929 [TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer risk of flat low-grade dysplasia in inflammatory bowel disease: a systematic review and proportion meta-analysis. Lauricella S; Fabris S; Sylla P Surg Endosc; 2023 Jan; 37(1):48-61. PubMed ID: 35920906 [TBL] [Abstract][Full Text] [Related]
40. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]